Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33349811
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Biomimetic nanoparticles as universal influenza vaccine
#MMPMID33349811
Wang F
; Chen G
; Zhao Y
Smart Mater Med
2020[]; 1
(?): 21-23
PMID33349811
show ga
Pandemic virus infections pose a major public health threat globally. Much
efforts have been devoted to suppress the virus, including vaccine prevention,
autoimmunity enhancement, and anti-virus drugs treatment. Among these strategies,
development of novel and improved vaccine technologies attracts broad attention
as they can nip the virus outbreak in the bud and avoid the appearance of public
health emergency. However, current influenza vaccines only provide protection
against homologous viruses. Therefore, chemical technologies are being employed
for the development of new and improved vaccine, such as chitosan, plant
polysaccharides and virus-like particles. In addition, recently, Wang et al.
offered a promising means to develop universal viral vaccine through biomimetic
nanoparticles and heterosubtypic protection could be achieved. These strategies
with multidisciplinary collaboration are promising to make conceptual and
technological advances of modern vaccinology to address pandemic virus
infections.
free
free
free
